185 related articles for article (PubMed ID: 18056630)
1. Structural basis for reduced FGFR2 activity in LADD syndrome: Implications for FGFR autoinhibition and activation.
Lew ED; Bae JH; Rohmann E; Wollnik B; Schlessinger J
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19802-7. PubMed ID: 18056630
[TBL] [Abstract][Full Text] [Related]
2. Lacrimo-auriculo-dento-digital syndrome is caused by reduced activity of the fibroblast growth factor 10 (FGF10)-FGF receptor 2 signaling pathway.
Shams I; Rohmann E; Eswarakumar VP; Lew ED; Yuzawa S; Wollnik B; Schlessinger J; Lax I
Mol Cell Biol; 2007 Oct; 27(19):6903-12. PubMed ID: 17682060
[TBL] [Abstract][Full Text] [Related]
3. Mutations in different components of FGF signaling in LADD syndrome.
Rohmann E; Brunner HG; Kayserili H; Uyguner O; Nürnberg G; Lew ED; Dobbie A; Eswarakumar VP; Uzumcu A; Ulubil-Emeroglu M; Leroy JG; Li Y; Becker C; Lehnerdt K; Cremers CW; Yüksel-Apak M; Nürnberg P; Kubisch C; Schlessinger J; van Bokhoven H; Wollnik B
Nat Genet; 2006 Apr; 38(4):414-7. PubMed ID: 16501574
[TBL] [Abstract][Full Text] [Related]
4. Lacrimo-auriculo-dento-digital syndrome: A novel mutation in a Korean family and review of literature.
Ryu YH; Kyun Chae J; Kim JW; Lee S
Mol Genet Genomic Med; 2020 Oct; 8(10):e1412. PubMed ID: 32715658
[TBL] [Abstract][Full Text] [Related]
5. LADD syndrome with glaucoma is caused by a novel gene.
Simpson A; Avdic A; Roos BR; DeLuca A; Miller K; Schnieders MJ; Scheetz TE; Alward WL; Fingert JH
Mol Vis; 2017; 23():179-184. PubMed ID: 28400699
[TBL] [Abstract][Full Text] [Related]
6. The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors.
Byron SA; Chen H; Wortmann A; Loch D; Gartside MG; Dehkhoda F; Blais SP; Neubert TA; Mohammadi M; Pollock PM
Neoplasia; 2013 Aug; 15(8):975-88. PubMed ID: 23908597
[TBL] [Abstract][Full Text] [Related]
7. Development of covalent inhibitors that can overcome resistance to first-generation FGFR kinase inhibitors.
Tan L; Wang J; Tanizaki J; Huang Z; Aref AR; Rusan M; Zhu SJ; Zhang Y; Ercan D; Liao RG; Capelletti M; Zhou W; Hur W; Kim N; Sim T; Gaudet S; Barbie DA; Yeh JR; Yun CH; Hammerman PS; Mohammadi M; Jänne PA; Gray NS
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4869-77. PubMed ID: 25349422
[TBL] [Abstract][Full Text] [Related]
8. TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
Goyal L; Shi L; Liu LY; Fece de la Cruz F; Lennerz JK; Raghavan S; Leschiner I; Elagina L; Siravegna G; Ng RWS; Vu P; Patra KC; Saha SK; Uppot RN; Arellano R; Reyes S; Sagara T; Otsuki S; Nadres B; Shahzade HA; Dey-Guha I; Fetter IJ; Baiev I; Van Seventer EE; Murphy JE; Ferrone CR; Tanabe KK; Deshpande V; Harding JJ; Yaeger R; Kelley RK; Bardelli A; Iafrate AJ; Hahn WC; Benes CH; Ting DT; Hirai H; Getz G; Juric D; Zhu AX; Corcoran RB; Bardeesy N
Cancer Discov; 2019 Aug; 9(8):1064-1079. PubMed ID: 31109923
[TBL] [Abstract][Full Text] [Related]
9. A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases.
Chen H; Ma J; Li W; Eliseenkova AV; Xu C; Neubert TA; Miller WT; Mohammadi M
Mol Cell; 2007 Sep; 27(5):717-30. PubMed ID: 17803937
[TBL] [Abstract][Full Text] [Related]
10. A requirement for Fgfr2 in middle ear development.
Rigueur D; Roberts RR; Bobzin L; Merrill AE
Genesis; 2019 Jan; 57(1):e23252. PubMed ID: 30253032
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic Cysteine Removal Mutations in FGFR Extracellular Domains Stabilize Receptor Dimers and Perturb the TM Dimer Structure.
Sarabipour S; Hristova K
J Mol Biol; 2016 Oct; 428(20):3903-3910. PubMed ID: 27596331
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of a novel FGFR2 mutation, E731K, in craniosynostosis.
Park J; Park OJ; Yoon WJ; Kim HJ; Choi KY; Cho TJ; Ryoo HM
J Cell Biochem; 2012 Feb; 113(2):457-64. PubMed ID: 21928350
[TBL] [Abstract][Full Text] [Related]
13. Elucidating the Role of Wildtype and Variant FGFR2 Structural Dynamics in (Dys)Function and Disorder.
Lian Y; Bodian D; Shehu A
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674107
[TBL] [Abstract][Full Text] [Related]
14. Two FGF Receptor Kinase Molecules Act in Concert to Recruit and Transphosphorylate Phospholipase Cγ.
Huang Z; Marsiglia WM; Basu Roy U; Rahimi N; Ilghari D; Wang H; Chen H; Gai W; Blais S; Neubert TA; Mansukhani A; Traaseth NJ; Li X; Mohammadi M
Mol Cell; 2016 Jan; 61(1):98-110. PubMed ID: 26687682
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric tyrosine kinase arrangements in activation or autophosphorylation of receptor tyrosine kinases.
Bae JH; Schlessinger J
Mol Cells; 2010 May; 29(5):443-8. PubMed ID: 20432069
[TBL] [Abstract][Full Text] [Related]
16. A novel mode of protein kinase inhibition exploiting hydrophobic motifs of autoinhibited kinases: discovery of ATP-independent inhibitors of fibroblast growth factor receptor.
Eathiraj S; Palma R; Hirschi M; Volckova E; Nakuci E; Castro J; Chen CR; Chan TC; France DS; Ashwell MA
J Biol Chem; 2011 Jun; 286(23):20677-87. PubMed ID: 21454610
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.
Ibrahimi OA; Eliseenkova AV; Plotnikov AN; Yu K; Ornitz DM; Mohammadi M
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7182-7. PubMed ID: 11390973
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes.
Bryant MR; Marta CB; Kim FS; Bansal R
Glia; 2009 Jul; 57(9):935-46. PubMed ID: 19053057
[TBL] [Abstract][Full Text] [Related]
19. LADD syndrome is caused by FGF10 mutations.
Milunsky JM; Zhao G; Maher TA; Colby R; Everman DB
Clin Genet; 2006 Apr; 69(4):349-54. PubMed ID: 16630169
[TBL] [Abstract][Full Text] [Related]
20. Endothelial fibroblast growth factor receptor signaling is required for vascular remodeling following cardiac ischemia-reperfusion injury.
House SL; Castro AM; Lupu TS; Weinheimer C; Smith C; Kovacs A; Ornitz DM
Am J Physiol Heart Circ Physiol; 2016 Mar; 310(5):H559-71. PubMed ID: 26747503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
